2016
DOI: 10.5603/kp.a2016.0053
|View full text |Cite
|
Sign up to set email alerts
|

Thickening of the epicardial adipose tissue can be alleviated by thyroid hormone replacement therapy in patients with subclinical hypothyroidism

Abstract: A b s t r a c tBackground: Subclinical hypothyroidism (SCH) is a common disorder which has adverse cardiovascular effects. Epicardial adipose tissue (EAT), a novel marker of cardiovascular risk, is increased in SCH. Aim:We aimed to investigate whether L-thyroxine treatment can reverse the thickening of EAT in SCH. Methods:Forty-four patients with SCH and 42 euthyroid control subjects were included. EAT thickness was measured using transthoracic echocardiography at baseline and after restoration of the euthyroi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(5 citation statements)
references
References 18 publications
0
5
0
Order By: Relevance
“… Author Year Country Participants (SCH/EU) Age (SCH/EU) Study design TSH cutoff value T4 measured? Measure outcomes NOS Score Ali Aydogdu 33 2017 Turkey 30/30 37.70 ± 13.54/40.96 ± 13.39 Case-control study ≥5.5 mIU/L + EAT thickness 7 Pramila Kalra 39 2016 Canada 58/49 31.83 ± 8.91/32.42 ± 9.98 Case-control study >4.5 mIU/L + PWV 5 Edip Unal 50 2017 Turkey 38/38 8.1 ± 3.6/8.9 ± 2.4 Case-control study >4.2 mIU/L + CIMT 8 Irmak Sayin 48 2016 Turkey 44/42 41.2 ± 15.9/42.1 ± 13.5 Case-control study >5.0 mIU/L + EAT thickness 8 Mustafa Altay 30 2017 Turkey 35/30 34.4 ± 10.3/32.5 ± 7.5 Case-control study + CIMT 4 Yasemin Isik-Balci 38 2016 Turkey 53/31 9.25 ± 4.29/7.19 ± 5.15 Case-control study + CIMT 4 Dilek Arpaci 31 2016 Turkey 41/35 34.07 ± 6.70/31.82 ± 5.57 Case-control study >5.4 mIU/L + EA...…”
Section: Methodsmentioning
confidence: 99%
“… Author Year Country Participants (SCH/EU) Age (SCH/EU) Study design TSH cutoff value T4 measured? Measure outcomes NOS Score Ali Aydogdu 33 2017 Turkey 30/30 37.70 ± 13.54/40.96 ± 13.39 Case-control study ≥5.5 mIU/L + EAT thickness 7 Pramila Kalra 39 2016 Canada 58/49 31.83 ± 8.91/32.42 ± 9.98 Case-control study >4.5 mIU/L + PWV 5 Edip Unal 50 2017 Turkey 38/38 8.1 ± 3.6/8.9 ± 2.4 Case-control study >4.2 mIU/L + CIMT 8 Irmak Sayin 48 2016 Turkey 44/42 41.2 ± 15.9/42.1 ± 13.5 Case-control study >5.0 mIU/L + EAT thickness 8 Mustafa Altay 30 2017 Turkey 35/30 34.4 ± 10.3/32.5 ± 7.5 Case-control study + CIMT 4 Yasemin Isik-Balci 38 2016 Turkey 53/31 9.25 ± 4.29/7.19 ± 5.15 Case-control study + CIMT 4 Dilek Arpaci 31 2016 Turkey 41/35 34.07 ± 6.70/31.82 ± 5.57 Case-control study >5.4 mIU/L + EA...…”
Section: Methodsmentioning
confidence: 99%
“…The reason for this finding could be only speculated and further studies are needed concerning regional fat distribution (e.g. visceral and/or epicardial) in both active males and females in the context of normal circulating TSH (Korkmaz et al, 2013;Belen et al, 2015;Sayin et al, 2016).…”
Section: Discussionmentioning
confidence: 99%
“…The reason for this finding could be only speculated and further studies are needed concerning regional fat distribution (e.g. visceral and/or epicardial) in both active males and females in the context of normal circulating TSH [30][31][32].…”
Section: Discussionmentioning
confidence: 99%